BKD Wealth Advisors LLC raised its holdings in Colgate-Palmolive (NYSE:CL) by 7.1% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 49,400 shares of the company’s stock after purchasing an additional 3,275 shares during the quarter. BKD Wealth Advisors LLC’s holdings in Colgate-Palmolive were worth $3,541,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of CL. Amalgamated Bank increased its stake in shares of Colgate-Palmolive by 0.7% during the first quarter. Amalgamated Bank now owns 110,439 shares of the company’s stock worth $7,916,000 after acquiring an additional 806 shares during the period. Summit Trail Advisors LLC increased its stake in shares of Colgate-Palmolive by 7,820.7% during the first quarter. Summit Trail Advisors LLC now owns 232,157 shares of the company’s stock worth $232,000 after acquiring an additional 229,226 shares during the period. Rational Advisors LLC increased its stake in shares of Colgate-Palmolive by 13.2% during the first quarter. Rational Advisors LLC now owns 7,704 shares of the company’s stock worth $552,000 after acquiring an additional 896 shares during the period. Catalyst Capital Advisors LLC increased its stake in shares of Colgate-Palmolive by 16.4% during the first quarter. Catalyst Capital Advisors LLC now owns 41,445 shares of the company’s stock worth $2,971,000 after acquiring an additional 5,835 shares during the period. Finally, CIBC World Markets Inc. increased its stake in shares of Colgate-Palmolive by 41.7% during the first quarter. CIBC World Markets Inc. now owns 94,185 shares of the company’s stock worth $6,751,000 after acquiring an additional 27,731 shares during the period. Institutional investors own 73.07% of the company’s stock.
In other Colgate-Palmolive news, insider Daniel B. Marsili sold 19,500 shares of the company’s stock in a transaction dated Monday, April 16th. The shares were sold at an average price of $71.85, for a total value of $1,401,075.00. Following the sale, the insider now owns 77,935 shares of the company’s stock, valued at $5,599,629.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Vice Chairman Franck J. Moison sold 80,000 shares of the company’s stock in a transaction dated Tuesday, May 15th. The shares were sold at an average price of $61.75, for a total transaction of $4,940,000.00. The disclosure for this sale can be found here. Insiders sold 161,579 shares of company stock worth $10,215,058 in the last ninety days. Insiders own 1.02% of the company’s stock.
CL stock opened at $64.00 on Wednesday. The stock has a market cap of $56.47 billion, a P/E ratio of 22.30, a P/E/G ratio of 2.61 and a beta of 0.75. Colgate-Palmolive has a 52 week low of $61.28 and a 52 week high of $77.91. The company has a current ratio of 1.08, a quick ratio of 0.75 and a debt-to-equity ratio of 64.85.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, April 27th. The company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a net margin of 13.30% and a return on equity of 1,486.69%. The company had revenue of $4 billion for the quarter, compared to the consensus estimate of $4.01 billion. During the same quarter in the prior year, the firm earned $0.67 earnings per share. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. equities analysts predict that Colgate-Palmolive will post 3.15 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, August 15th. Shareholders of record on Wednesday, July 18th will be issued a $0.42 dividend. This represents a $1.68 annualized dividend and a dividend yield of 2.63%. The ex-dividend date is Tuesday, July 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.54%.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.